COVID-19 human challenge trials – what research ethics committees need to consider
To reduce the global burden of the COVID-19 pandemic, there is an urgent need to develop a safe vaccine. Vaccine development usually takes many years as it goes through several different phases. To hasten COVID-19 vaccine development, it has been suggested that the final stage could be replaced with...
Main Authors: | Lisa Tambornino, Dirk Lanzerath |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-07-01
|
Series: | Research Ethics Review |
Online Access: | https://doi.org/10.1177/1747016120943635 |
Similar Items
-
The ethics of COVID-19 tracking apps – challenges and voluntariness
by: Renate Klar, et al.
Published: (2020-07-01) -
Challenges and proposed solutions in making clinical research on COVID-19 ethical: a status quo analysis across German research ethics committees
by: Alice Faust, et al.
Published: (2021-07-01) -
Research ethics challenges during the COVID-19 pandemic: what should and what should not be done
by: Atif Abdulhamid Katib
Published: (2020-09-01) -
Preventing ethics dumping: the challenges for Kenyan research ethics committees
by: Kate Chatfield, et al.
Published: (2021-01-01) -
The Challenge of Timely, Responsive and Rigorous Ethics Review of Disaster Research: Views of Research Ethics Committee Members.
by: Matthew Hunt, et al.
Published: (2016-01-01)